<?xml version="1.0" encoding="UTF-8"?>
<ref id="B158-cancers-13-02036">
 <label>158.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Selle</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Fletcher</surname>
    <given-names>J.R.</given-names>
   </name>
   <name>
    <surname>Tuson</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Schmitt</surname>
    <given-names>D.S.</given-names>
   </name>
   <name>
    <surname>McMillan</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Vridhambal</surname>
    <given-names>G.S.</given-names>
   </name>
   <name>
    <surname>Rivera</surname>
    <given-names>A.J.</given-names>
   </name>
   <name>
    <surname>Montgomery</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Fortier</surname>
    <given-names>L.C.</given-names>
   </name>
   <name>
    <surname>Barrangou</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>In Vivo targeting of clostridioides difficile using phage-delivered CRISPR-Cas3 antimicrobials</article-title>
  <source>mBio</source>
  <year>2020</year>
  <fpage>11</fpage>
  <pub-id pub-id-type="doi">10.1128/mBio.00019-20</pub-id>
 </element-citation>
</ref>
